Cosmos Health (COSM) Stock Price, News & Analysis

Company Overview

Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names. The company serves wholesale distributors and other healthcare providers, such as clinics, government agencies, independent retail and specialty pharmacies and independent specialty distributors. It sells its products through independent wholesale distributors. Cosmos Health Inc. was incorporated in 2009 and is headquartered in Chicago, Illinois.

Key Stats

• Today's Range: $0.20 to $0.25
• 50-Day Range: $0.17 to $0.38
• 52-Week Range: $0.16 to $1.32
• Volume: 18.58 million shs
• Average Volume: 17.62 million shs
• Market Capitalization: $14.72 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Sell

Cosmos Health Stock Analysis - MarketRank™

Cosmos Health scored higher than 35% of companies evaluated by MarketBeat, and ranked 647th out of 850 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 0.7 / 5
• Analyst Rating: Sell

Consensus Rating

Cosmos Health has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.

Amount of Analyst Coverage

Cosmos Health has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for Cosmos Health are expected to grow in the coming year, from ($0.06) to $0.07 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Cosmos Health is -0.37, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Cosmos Health is -0.37, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Cosmos Health has a P/B Ratio of 0.53. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

5.11% of the float of Cosmos Health has been sold short.

Short Interest Ratio / Days to Cover

Cosmos Health has a short interest ratio ("days to cover") of 0.16, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Cosmos Health has recently increased by 163.24%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Cosmos Health does not currently pay a dividend.

Dividend Growth

Cosmos Health does not have a long track record of dividend growth.

News and Social Media

• Score: 3.4 / 5
• News Sentiment: 0.43

News Sentiment

Cosmos Health has a news sentiment score of 0.43. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.58 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 6 news articles for Cosmos Health this week, compared to 5 articles on an average week.

Search Interest

9 people have searched for COSM on MarketBeat in the last 30 days. This is an increase of 350% compared to the previous 30 days.

MarketBeat Follows

6 people have added Cosmos Health to their MarketBeat watchlist in the last 30 days. This is an increase of 200% compared to the previous 30 days.

Company Ownership

• Score: 4.4 / 5
• Insider Trading: Acquiring Shares

Cluster Insider Buying

2 insiders have purchased shares of Cosmos Health in the last three months. Multiple insiders buying is a strong bullish signal.

Net Insider Buying

Over the last three months, insiders have purchased a net $249,240.00 in company stock, which represents 1.6934% of the company's market cap.

Insider Buying vs. Insider Selling

In the past three months, Cosmos Health insiders have bought more of their company's stock than they have sold. Specifically, they have bought $249,240.00 in company stock and sold $0.00 in company stock.

Percentage Held by Insiders

26.15% of the stock of Cosmos Health is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

12.61% of the stock of Cosmos Health is held by institutions.

Company Calendar

• Last Earnings: 5/21/2026
• Today: 7/05/2026
• Next Earnings (Estimated): 8/17/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED - DRUGS
• Sub-Industry: Wholesale
• Current Symbol: NASDAQ:COSM
• CIK: 1474167
• Web: www.cosmosholdingsinc.com
• Phone: (312) 536-3102
• Fax: N/A
• Employees: 100
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): ($0.64)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$19.15 million
• Net Margins: -30.41%
• Pretax Margin: -30.41%
• Return on Equity: -52.85%
• Return on Assets: -17.87%

Debt

• Debt-to-Equity Ratio: 0.31
• Current Ratio: 1.08
• Quick Ratio: 0.92

Sales & Book Value

• Annual Sales: $69.49 million
• Price / Sales: 0.21
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.45 per share
• Price / Book: 0.53

Miscellaneous

• Outstanding Shares: 62,078,000
• Free Float: 45,845,000
• Market Cap: $14.72 million
• Optionable: Optionable
• Beta: 4.83